Medical Xpress news
Medical Xpress / A protective gel for a future without insulin injections
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing ...
Medical Xpress / Age does not appear to drive cardiovascular risk in pregnancy
Underlying cardiovascular risk, rather than older age, drives complications such as venous thromboembolism, cardiomyopathy and heart failure during pregnancy, according to new Weill Cornell Medicine research. The findings ...
Medical Xpress / Written in the eye: How the retina's biological age could help predict osteoporosis risk
Eyes, the high-resolution biological devices that help us visualize the outside world, are now being used as a portal to assess our internal health. Scientists have found that a closer evaluation of how one's retina is aging ...
Medical Xpress / 'Garbage collectors' of the brain grind to a halt in fatal multiple system atrophy
Multiple system atrophy (MSA) is a rare and fatal brain disorder with no available treatment or cure, attacking the nervous system, balance, and the ability to move. The disease in many ways resembles Parkinson's disease, ...
Medical Xpress / Statistical method may overstate Alzheimer's drugs' cognitive benefits by 29 times
A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.
Medical Xpress / Medicare Advantage broker payments potentially hit $10 billion annually, study finds
New research offers one of the clearest pictures yet on just how large the Medicare Advantage insurance broker market has become. Published as a research letter in JAMA Internal Medicine, the study by health policy scholars ...
Medical Xpress / New drug target identified for Fragile X syndrome
UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic cause of intellectual disability and autism that affects roughly one in 2,000 boys.
Medical Xpress / AI-powered CPR coach outperforms 911 dispatchers in guiding bystander resuscitation
A new study from scientists at the University of California San Diego in collaboration with the University of Pittsburgh School of Medicine, Johns Hopkins University, and other institutions, demonstrates that an artificial ...
Medical Xpress / Why an off-label autism drug suddenly took off, despite limited large-scale evidence
Researchers from the University of California San Diego found that prescriptions for leucovorin, a drug sometimes used off-label for autism spectrum disorder (ASD), rose sharply among children after widespread media attention ...
Medical Xpress / Key multiple sclerosis models reveal different damage timelines, offering roadmap for myelin repair studies
More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, optic nerves, and spine. MS is an unpredictable disorder, with symptoms—such as overwhelming fatigue, ...
Medical Xpress / Open-access tool decodes DNA change patterns in breast cancer
A study led by Dr. Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore), has identified eight new "signatures" of DNA patterns (gains and/or losses) in breast cancer. By analyzing ...
Medical Xpress / Once-nightly pill treats causes of airway collapse to control obstructive sleep apnea in large clinical trial
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to treat OSA by addressing ...
